Showing results (631-640 of 725) with videos related to

Sort By:
Pageof 73
The Journal of Veterinary Medical Science|April 4, 2017
Epidemiological study on feline gastric Helicobacter spp. in JapanSanae Kubota-Aizawa, Koichi Ohno, Hideyuki Kanemoto, et al.
International Journal of Cancer|June 19, 1993
Allelic loss in ovarian cancerT L Yang-Feng, H Han, K C Chen, et al.
The American Journal of Pathology|July 1, 1990
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1B M Kacinski, D Carter, K Mittal, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 22, 2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidenceChristine Gruessner, Angelika Gruessner, Katherine Glaser, et al.
Gene|October 18, 2015
Association of the microRNA-Single Nucleotide Polymorphism rs2910164 in miR146a with sporadic breast cancer susceptibility: A case control studyAkanksha Upadhyaya, Robert A Smith, Diego Chacon-Cortes, et al.
The Lancet. Oncology|July 19, 2018
Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled studyGeoffrey D Coughlin, John W Yaxley, Suzanne K Chambers, et al.
BMC Cancer|December 15, 2011
Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trialDaniel A Galvão, Dennis R Taaffe, Prue Cormie, et al.
Clinical Colorectal Cancer|February 5, 2018
Cardiorespiratory Fitness and Body Composition Responses to Different Intensities and Frequencies of Exercise Training in Colorectal Cancer SurvivorsJames L Devin, David G Jenkins, Andrew T Sax, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assayS Wilson, J K Chambers, J E Park, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1990
The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patientsB M Kacinski, S K Chambers, E R Stanley, et al.
Pageof 73